Interaksi Eplerenon dan Kuinapril dan hidroklorotiazid

Eplerenon dan Kuinapril dan hidroklorotiazid: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Eplerenon (Eplerenone) · berlaku sejak 2025-06-23

Mayor

…• serum creatinine > 2.0 mg/dL in males or >1.8 mg/dL in females, • creatinine clearance < 50 mL/min, or • concomitant administration of potassium supplements or potassium-sparing diuretics (e.g., amiloride, spironolactone, or triamterene) [see Warnings and Precautions (5.1) , Adverse Reactions (6.2) , Drug Interactions (7) , and Clinical Pharmacology (12.3)…

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

• Concomitant use of potassium supplements or potassium-sparing diuretics ( 4 )

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Moderat

ACE Inhibitors and Angiotensin II Receptor Antagonists The risk of hyperkalemia increases when eplerenone is used in combination with an ACE inhibitor and/or an ARB.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Lithium toxicity has been reported in patients receiving lithium concomitantly with diuretics and ACE inhibitors.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

The administration of other potassium-sparing antihypertensives with NSAIDs has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Dari label Kuinapril dan hidroklorotiazid (Quinapril and Hydrochlorothiazide) · berlaku sejak 2023-12-11

Mayor

…sometimes associated with oliguria and/or progressive azotemia, and rarely acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis or severe volume and/or salt depletion of any etiology.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

The thiazide component of quinapril and hydrochlorothiazide tablets may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic- blocking drugs.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Such patients should be followed closely for the first 2 weeks of treatment and whenever the dosage of quinapril or diuretic is increased.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

In clinical studies in hypertensive patients with unilateral renal artery stenosis, treatment with ACE inhibitors was associated with increases in blood urea nitrogen and serum creatinine; these increases were reversible upon discontinuation of ACE inhibitor, concomitant diuretic, or both.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Some quinapril-treated hypertensive patients with no apparent preexisting renal vascular diseases have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when quinapril has been given concomitantly with a diuretic.

Peringatanberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.